Evidence map›Paper›PMID 26120870›Full record

ArticleJournal of the American Chemical Society2015

Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity.

David M Mofford, Spencer T Adams, G S Kiran Kumar Reddy, Gadarla Randheer Reddy, Stephen C Miller

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Caged luciferins for bioluminescent activity-based sensing.Current opinion in biotechnology · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. An inner light.Lab animal · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David M MoffordDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
Spencer T AdamsDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
G S Kiran Kumar ReddyDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
Gadarla Randheer ReddyDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
Stephen C MillerDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
University of Massachusetts Chan Medical School · US

Funding

Enhanced synthetic luciferin substrates for firefly luciferaseR01EB013270 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MILLER, STEPHEN C. · 2011 to 2020
$2.9M
Illuminating serine hydrolase activityR01DA039961 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MILLER, STEPHEN C. · 2015 to 2018
$1.9M
NIBIB NIH HHS R01 EB013270NIBIB NIH HHS R01EB013270NIDA NIH HHS R01 DA039961NIDA NIH HHS R01DA039961
6 · The paper itself

Abstract

Firefly luciferase is homologous to fatty acyl-CoA synthetases. We hypothesized that the firefly luciferase substrate d-luciferin and its analogs are fatty acid mimics that are ideally suited to probe the chemistry of enzymes that release fatty acid products. Here, we synthesized luciferin amides and found that these molecules are hydrolyzed to substrates for firefly luciferase by the enzyme fatty acid amide hydrolase (FAAH). In the presence of luciferase, these molecules enable highly sensitive and selective bioluminescent detection of FAAH activity in vitro, in live cells, and in vivo. The potency and tissue distribution of FAAH inhibitors can be imaged in live mice, and luciferin amides serve as exemplary reagents for greatly improved bioluminescence imaging in FAAH-expressing tissues such as the brain.

Indexed as

AmidesAmidohydrolasesAnimalsBenzothiazolesCHO CellsCricetulusEnzyme AssaysEnzyme InhibitorsFatty Acid Amide HydrolasesHeLa CellsHumansHydrolysisLuciferases, FireflyLuminescent AgentsMiceOptical ImagingAmidesAmidohydrolasesBenzothiazolesD-luciferinEnzyme InhibitorsFatty Acid Amide HydrolasesLuciferases, FireflyLuminescent AgentsPF 3845PiperidinesPyridines

Identifiers

PMID26120870
PMCPMC4507478
OpenAlexW2342108625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.